This finding suggests that the regulation of Bdnf and Il-1β signaling by 0.5% GORZ treatment promotes possible neural mechanisms in the hippocampus that mediate chronic alcohol-induced anxiety-like behaviors. The gene discussed is BDNF; the disease is Anxiety.